AUG 19, 2021 7:34 AM PDT

Age of Colorectal Cancer Diagnosis Does not Affect Tumor Growth

WRITTEN BY: Annie Lennon

Early-onset colorectal cancer progresses in the same way as average onset colorectal cancer. The corresponding study was published in the Journal of the National Cancer Institute

Colorectal cancer is the third most commonly diagnosed cancer and the second leading cause of cancer deaths in the US. While it is most commonly diagnosed between the ages of 65 and 74, since the mid 1990’s, incidence rates of the disease occurring in those under 50 years old have increased between 1% and 2% per year. 

In the current study, researchers compared the progression of early-onset and average-onset colorectal cancer using data from the Memorial Sloan Kettering Cancer Center collected between 2014 and 2019. 

All in all, they had access to data from 759 patients who developed the disease before the age of 50- characterized as early-onset colorectal cancer- and 687 patients diagnosed with the disease aged 50 years or older- characterized as average-onset colorectal cancer. They compared the location of tumors, symptoms at diagnosis, risk for hereditary colorectal cancer, and other tumor molecular features. 

Importantly, the researchers found the genetic makeup of the tumors in both groups of patients, and their responses to treatment at advanced stages, were indistinguishable. This, says the researchers, suggests that early-onset colorectal cancer is not biologically distinct from average-onset colorectal cancer. They also noted that more aggressive treatments for early-onset colorectal cancer were neither effective nor necessary. 

The researchers did note some differences between the two onset times of the disease, however. They noted that those who develop the disease earlier were more likely to have tumors on the left side of the body, and were more likely to experience rectal bleeding, abdominal pain, and have a genetic predisposition for the disease.

“The study noted no specific findings to differentiate early-onset colorectal cancer patients from average-onset colorectal cancer patients,” said ­­­­­­­­­­­­Cathy Eng of Vanderbilt-Ingram Cancer Center, who wrote an editorial to accompany the study. 

“I am hopeful with increased awareness and education, other investigators will collect additional data inclusive of a diverse patient population to determine if the findings from this study apply to the general public impacted by early-onset colorectal cancer," she added. 

 

Sources: Journal of the National Cancer Institute, EurekAlert

About the Author
  • Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
JUL 22, 2021
Cell & Molecular Biology
Cancer Cells in the Lab Aren't Like Cancer Cells in the Body
JUL 22, 2021
Cancer Cells in the Lab Aren't Like Cancer Cells in the Body
To study biology, researchers need models. Once those models might have been a bit limited to organisms like rats or mic ...
AUG 01, 2021
Genetics & Genomics
Rethinking the Cause of Mutations That Lead to Melanoma
AUG 01, 2021
Rethinking the Cause of Mutations That Lead to Melanoma
Throughout our lives, new cells often replace the ones that become damaged or worn out. As cells divide, they have to re ...
AUG 18, 2021
Technology
Tracking System Maps How Cancer Cells Evolve, Providing New Treatment Insights
AUG 18, 2021
Tracking System Maps How Cancer Cells Evolve, Providing New Treatment Insights
All cells in a tumor share some genetic similarities, but also have key differences, often hindering effective treatment ...
OCT 10, 2021
Cell & Molecular Biology
DNA Can Reveal Treatments for Lung Cancer in 'Never-Smoked' Patients
OCT 10, 2021
DNA Can Reveal Treatments for Lung Cancer in 'Never-Smoked' Patients
There is a well-known causal connection between smoking and lung cancer, and most research on lung cancer has been focus ...
NOV 05, 2021
Cancer
The Labroots 2021 Cancer Research and Oncology Virtual Event Poster Winner
NOV 05, 2021
The Labroots 2021 Cancer Research and Oncology Virtual Event Poster Winner
Every year, Labroots hosts an exciting series of Virtual Events that focus on various scientific topics. These virtual m ...
NOV 24, 2021
Cannabis Sciences
Can Cannabis Treat Chemotherapy-induced Peripheral Neuropathy?
NOV 24, 2021
Can Cannabis Treat Chemotherapy-induced Peripheral Neuropathy?
Platinum-based chemotherapies such as oxaliplatin are used to treat gastrointestinal tumors, especially in the advanced ...
Loading Comments...